Effect of probiotic supplementation on the gut microbiota in very preterm infants: a systematic review
- 26 June 2024
- journal article
- review article
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 110 (1) , 57-67
Abstract
Objective: There is increasing evidence that probiotic supplementation in very preterm infants decreases the risk of necrotising enterocolitis (NEC), sepsis and mortality. The underlying mechanisms, including effects on the gut microbiota, are largely unknown. We aimed to systematically review the available literature on the effects of probiotic supplementation in very preterm infants on gut microbiota development.Design: A systematic review in Medline, Embase, Cochrane Library, CINAHL and Web of Science.Setting: Neonatal intensive care unit.Patients: Premature infants.Intervention: Probiotic supplementation.Main outcome measures: Gut microbiota.Results: A total of 1046 articles were screened, of which 29 were included. There was a large heterogeneity in study design, dose and type of probiotic strains, timepoints of sample collection and analysing techniques. Bifidobacteria and lactobacilli were the most used probiotic strains. The effects of probiotics on alpha diversity were conflicting; however, beta diversity was significantly different between probiotic-supplemented infants and controls in the vast majority of studies. In most studies, probiotic supplementation led to increased relative abundance of the supplemented strains and decreased abundance of genera such asClostridium,Streptococcus,KlebsiellaandEscherichia.Conclusions: Probiotic supplementation to preterm infants seems to increase the relative abundance of the supplemented strains with a concurrent decrease of potentially pathogenic species. These probiotic-induced microbial alterations may contribute to the decreased risk of health complications such as NEC. Future trials, including omics technologies to analyse both microbiota composition and function linked to health outcomes, are warranted to identify the optimal mixture and dosing of probiotic strains.PROSPERO registration number: CRD42023385204.Keywords
This publication has 55 references indexed in Scilit:
- Exploring the long-term colonisation and persistence of probiotic-prophylaxis species on the gut microbiome of preterm infants: a pilot studyEuropean Journal of Pediatrics, 2022
- Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infantsCell Host & Microbe, 2022
- Effects of Lactobacillus reuteri supplementation on the gut microbiota in extremely preterm infants in a randomized placebo-controlled trialCell Reports Medicine, 2021
- Assessment of Neonatal Intensive Care Unit Practices and Preterm Newborn Gut Microbiota and 2-Year Neurodevelopmental OutcomesJAMA Network Open, 2020
- Microbiota Supplementation with Bifidobacterium and Lactobacillus Modifies the Preterm Infant Gut Microbiota and Metabolome: An Observational StudyCell Reports Medicine, 2020
- The Microbiome of Infants Recruited to a Randomised Placebo-controlled Probiotic Trial (PiPS Trial)EBioMedicine, 2017
- Preterm neonatal morbidity and mortality by gestational age: a contemporary cohortAmerican Journal of Obstetrics and Gynecology, 2016
- Intestinal microbiota and its relationship with necrotizing enterocolitisPediatric Research, 2015
- Cross-colonization of infants with probiotic organisms in a neonatal unitJournal of Hospital Infection, 2014
- Probiotics for prevention of necrotizing enterocolitis in preterm infantsCochrane Database of Systematic Reviews, 2014